文献速递甲状腺与颈部外科

甲状腺全切联合碘消融对淋巴结复发甲状腺乳头状癌的影响

The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma.
PubMed 文献 · Surgery · 2019-05-22

该回顾性研究比较了淋巴结清扫 alone 与淋巴结清扫联合 completion thyroidectomy 及放射性碘治疗对甲状腺乳头状癌淋巴结复发患者的疗效。中位随访 10.2 年,两组总生存、无远处复发生存和无淋巴结复发生存无显著差异,但联合组手术时间更长、出血更多、术后甲状旁腺功能减退率更高。结论认为单纯淋巴结清扫是可接受的治疗选择。

要点

  • 对于甲状腺乳头状癌仅淋巴结复发患者,单纯淋巴结清扫与联合全切及碘治疗生存无差异。
  • 联合全切及碘治疗组手术时间更长、出血更多、术后甲状旁腺功能减退率更高。
  • 单纯淋巴结清扫可作为减少手术并发症的可接受治疗选择。

核心结论

  • 与淋巴结清扫联合 completion thyroidectomy 及放射性碘治疗相比,单纯淋巴结清扫是可接受的治疗选择,不降低至少 10 年生存,且减少手术缺点。

主要发现

  • LC&R 组与 L 组的总生存、无远处复发生存和无淋巴结复发生存无显著差异(P 分别为 .89、0.58 和 .22)。
  • LC&R 组手术时间更长、出血更多、术后甲状旁腺功能减退率更高(P 均 < .001)。

临床怎么用

  • 对于甲状腺乳头状癌仅淋巴结复发的患者,可考虑单纯淋巴结清扫以避免 completion thyroidectomy 及放射性碘治疗带来的手术并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although lobectomy is considered acceptable as a primary surgical treatment for papillary thyroid carcinoma in properly selected patients, a standard treatment for postlobectomy lymph node recurrence has not been established. Here we compared the effectiveness of therapy with lymphadenectomy alone to that of treatment with completion thyroidectomy and lymphadenectomy followed by radioactive iodine. METHODS: This was a retrospective study of patients with papillary thyroid carcinoma who underwent surgery for lymph node recurrence in the period from January 2003 to December 2008, all of whom had previously undergone initial lobectomy with or without lymph node dissection. One-hundred and twenty-five patients were included in the primary analysis. RESULTS: Ninety-eight of these patients underwent lymphadenectomy alone (L group), and 27 received lymphadenectomy and completion thyroidectomy followed by radioactive iodine (LC&R group). The median follow-up time was 10.2 years. The overall survival, distant relapse-free survival, and lymph node relapse-free survival were not significantly different between the LC&R and L groups (P = .89, 0.58, and .22, respectively), whereas the LC&R group patients had significantly longer operation time, higher blood loss, and a higher rate of postoperative hypoparathyroidism compared with the L group (P < .001, respectively). CONCLUSION: Compared with completion thyroidectomy and lymphadenectomy followed by radioactive iodine, lymphadenectomy alone was considered an acceptable therapeutic option which decreased the surgical disadvantages but did not decrease survival for at least 10 years after recurrence surgery for PTC patients with only lymph node recurrence.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Saito Y, Matsuzu K, Sugino K, et al. The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma. Surgery. 2019. PMID: 31128851. doi:10.1016/j.surg.2019.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。